Adjust Font Sizing:

Jazz turned down by FDA Advisory Board

August 23, 2010 an FDA Advisory Panel turned down Jazz Pharmaceutical’s request to market Sodium Oxybate to treat Fibromyalgia.  read story

# # #
Date Created: August 29th, 2010
Last Updated: June 29th, 2011

Comments are closed.